Off-Label Prescription Injuries in New York City: Can You Sue the Doctor or Drug Maker?

Prescription drugs are generally approved by the U.S. Food and Drug Administration (FDA) for specific uses, doses, patient populations, and methods of administration. Doctors, however, may prescribe an FDA-approved drug for a different purpose. This is referred to as off-label prescribing, and it is generally lawful if the doctor believes the use is medically suitable.

However, just because something is legal does not mean it is appropriate. If an off-label medication causes harm because a doctor failed to exercise reasonable medical judgment, failed to communicate important risks, or offered inadequate warnings, an injured patient may be eligible to file a lawsuit. Who is accountable depends on how the drug was prescribed, what info was given, and what caused the injury.

What “Off-Label” Prescribing Means and Why It’s Legal

An off-label prescription occurs when a doctor administers an FDA-approved drug in a way that is not clearly stated on the drug’s approved labeling. This could include prescribing it for a different medical condition, at a different dose, or via a different route of administration.

The FDA generally allows healthcare providers to prescribe approved medications for unapproved purposes if they believe the treatment is medically necessary. The fact that a prescription was written off-label does not establish medical malpractice or product liability.

The legal question is whether the doctor and other potentially responsible parties acted appropriately under the circumstances and whether their conduct caused the patient’s injury.

When You Can Sue the Prescribing Doctor

An off-label prescription may establish a medical malpractice lawsuit if the physician deviated from the accepted standard of medical care, resulting in an injury. For example, a claim could emerge if a doctor prescribed a medicine for an inappropriate condition, overlooked known contraindications, recommended an unreasonable dosage, failed to examine a patient’s medical history, or failed to properly monitor the patient.

The fact that a medicine was supplied off-label is therefore significant, but it is not necessarily evidence of negligence. A clinician may have a valid medical rationale for using an off-label treatment. A successful malpractice claim typically requires evidence linking the doctor’s actions to the patient’s injuries.

Informed Consent: Did Your Doctor Have to Tell You It Was Off-Label?

The fact that a medicine is being used off-label can be relevant to informed consent, but New York’s informed-consent law is more concerned with material risks, alternatives, and advantages than with whether the FDA has approved that specific use.

What New York’s informed consent law (PHL §2805-d) requires

According to New York Public Health Law §2805-d, lack of informed consent occurs when a practitioner fails to disclose alternatives, risks, and benefits that a reasonable practitioner would have disclosed, allowing the patient to make an informed decision. The Act also requires proof that a reasonably prudent person in the patient’s position would have refused the treatment if fully informed and that the lack of informed consent was a direct cause of the injury.

This means that off-label status alone does not always constitute an informed-consent breach. The more pressing concern is whether the patient was denied information about serious hazards or reasonable alternatives that should have been revealed prior to treatment.

Why a signed consent form doesn’t automatically protect the doctor

A signed consent document is not always an adequate defense to a malpractice lawsuit. What the patient was told matters.

Section 2805-d particularly asks if the relevant risks and alternatives were communicated and whether the patient would have progressed if fully aware.

A signature may show that certain information was supplied, but it does not automatically relinquish a patient’s rights or demonstrate that the doctor followed the applicable standard of care. A patient may still have a claim if significant risks or alternatives were not sufficiently given or if the underlying treatment was administered negligently.

When You Can Sue the Drug Manufacturer

When a medication is defective, drug manufacturers may face product liability lawsuits, including claims based on inadequate warnings or instructions. However, demonstrating that an injury resulted from off-label usage does not necessarily prove the manufacturer’s responsibility.

A manufacturer is normally responsible for the safety and labeling of its products. The particular basis of culpability will be determined by the substance, the alleged flaw, the warnings supplied, and the circumstances surrounding the medication’s prescription and administration.

A manufacturer may alternatively argue that the harm was caused by the doctor’s prescription choice rather than a flaw in the product or its warnings. 

Brand-Name vs. Generic Drugs: Why It Can Change Your Case

The type of medication the patient took, whether brand-name or generic, can have a substantial impact on a drug-injury claim.

When a patient takes a brand-name drug, a claim may be directed at the company that manufactured or sold that specific product, depending on the alleged defect and applicable law. Generic-drug cases can be more problematic since federal law has limited certain failure-to-warn claims against generic manufacturers, whose labeling must generally match that of the brand-name drug.

New York courts have also reviewed, and typically rejected, attempts to hold a brand-name manufacturer liable for harm caused by a generic drug that it did not manufacture. The particular problem can vary depending on the facts and legal theory being argued.

Consequently, identifying the manufacturer of the specific drug the patient consumed is a crucial initial step in assessing a prescription drug injury.

Doctor or Drug Maker: Who’s Actually Responsible?

Occasionally the answer is one party, but in other circumstances, culpability may involve several parties.

A doctor may be held liable if the injury was caused by negligent prescribing, insufficient monitoring, or failure to disclose material dangers. A manufacturer may be held liable if the drug was defective or improperly labeled under an applicable product-liability basis.

The key issue is that an off-label prescription does not automatically render the doctor liable, nor does an accident automatically make the pharmaceutical corporation liable. The case demands an investigation of the medical decision, the drug’s hazards and warnings, the patient’s medical history, and the evidence linking each defendant’s actions to the damage.

Proving the Off-Label Drug Caused Your Injury

Causation might be one of the most difficult aspects of an off-label drug damage claim. It is not enough to demonstrate that a patient took a medicine and then developed a medical concern.

A claim may need medical evidence proving that the drug, dose, prescribing decision, inadequate warning, or another alleged flaw caused the damage. Medical records, prescription records, pharmacy records, drug labeling, scientific literature, expert medical testimony, and evidence of the patient’s condition before and after taking the medication may all be used in the investigation.

It is also necessary to examine other possible causes. The defense may point to a patient’s underlying medical condition, other medications, subsequent therapy, or unrelated health concerns as possible causes of the harm.

New York Deadlines: Two Different Clocks

New York CPLR §214-a limits medical malpractice claims against doctors to two years and six months from the claimed malpractice or, in some cases, the last treatment for the ailment. Exceptions may apply.

A manufacturer’s claim may include a separate limitations framework. CPLR §214-c establishes a three-year discovery period for personal injury claims resulting from a substance’s latent effects. The statute usually starts when the harm is found or could have been found, not when the exposure occurred. Importantly, §214-c does not apply to medical malpractice cases.

There is another key deadline for claims involving NYC Health + Hospitals or another government body. A claimant must normally serve a Notice of Claim within 90 days of the claim arising, subject to certain exclusions and regulations. A medical malpractice action against NYC Health + Hospitals may also be subject to a shorter municipal limitation period.

Injured by an Off-Label Prescription in New York City? Talk to a Drug Injury Lawyer

An off-label prescription does not imply negligence, and taking an off-label medication does not automatically grant a patient the right to sue. However, when a prescription results in an injury, it is critical to assess whether the doctor, medication manufacturer, or another accountable party breached a legal responsibility.

A New York lawyer specializing in drug injury can examine the patient’s medical records and prescription history to determine whether the doctor’s actions constituted malpractice, investigate potential product-liability claims, identify the manufacturer responsible for the medication, and determine which filing deadlines apply.

If you were seriously injured while using an off-label medicine in New York City, the attorneys at Greenberg & Stein P.C. can analyze your case and explain your legal options. Call 212-681-2535 to set up a free consultation.